Background Patients with active cancer have an increased risk of venous thromboembolism,
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …

Cardiovascular disease (CVD) is the leading cause of mortality in women. In fact, CVD is
responsible for a third of all deaths of women worldwide and half of all deaths of women over …

Background Post-thrombotic syndrome (PTS) is a common and burdensome complication
of deep venous thrombosis (DVT). Previous trials suggesting benefit of elastic compression …

Background The public health burden of venous thromboembolism, which includes deep vein
thrombosis and pulmonary embolism, is not fully known, and contemporary incidence and …

Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer.
These patients are at a high risk of VTE recurrence and bleeding during anticoagulant …

We critically assessed studies on the clinical importance, diagnosis, incidence, and
pathogenesis of peripheral vein infusion thrombophlebitis, including catheter-related and patient-…

Background Venous thromboembolism may be the earliest sign of cancer. Currently, there
is a great diversity in practices regarding screening for occult cancer in a person who has an …

Background Pulmonary embolism (PE)-related mortality is decreasing in Europe. However,
time trends in the USA and Canada remain uncertain because the most recent analyses of …

Background Venous thromboembolism (VTE) is a leading cause of morbidity and mortality
in hospitalized patients. Numerous randomized controlled trials (RCTs) show that using …

Introduction The risk of symptomatic deep vein thrombosis (DVT) among patients with non-small
cell lung cancer (NSCLC) has not been well studied. We conducted a retrospective …